Top 10 Medical VC Funds & Investors in Argentina (August 2026)

Portfolio highlights

• Gameet — Biotech startup. We improve the opportunities for procreation for millions worldwide by emulating natural reproductive processes in our devices.
• PILL.AR — PILL.AR is a biotechnology company that offers personalised medication for people.
• NotFossil — NotFossil is a biotechnology company that offers hydrocarbon bioremediation services for wastewater treatment.

Portfolio highlights

• Axenya — Axenya leverages the power of data to deliver personalized health, greater control, and cost savings. They design solutions for managing a company's corporate health.
• Asclepii — Multi-dimensional Wound Healing | Cell therapy is the future of human health. | Regenerative medicine for modern wound care.
• BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.

Portfolio highlights

• Oyster — Oyster is the only digital account that empowers business owners to grow. We help entrepreneurs achieve their business goals by simplifying their financial management.A financial platform designed to help you run your business from your phone Oyster Mastercard debit card sent to your office 24/7 fund transfers with no fees Bill payment forover 70 service providers in Mexico Discounts in 10,000 locations Send and manage invoicesOur platform saves time in every task and empowers entrepreneurs to make better financial decisions.
• BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.
• Cascade Biocatalysts — Cascade Biocatalysts is built on a novel way to immobilize enzymes. Our technology keeps enzymes active and stable under difficult industrial conditions.

Portfolio highlights

• Oncoliq — Oncoliq is a startup that is developing a screening method for early cancer detection based on liquid biopsy using a small blood sample. Our technology is based on the detection of panels of microRNAs by PCR and machine learning.

Portfolio highlights

• Oncoliq — Oncoliq is a startup that is developing a screening method for early cancer detection based on liquid biopsy using a small blood sample. Our technology is based on the detection of panels of microRNAs by PCR and machine learning.
• Calice — ounded in 2022, Calice is at the forefront of agricultural innovation. We specialize in computationally modeling biological and agronomic data of crops to predict and enhance their yield, quality, and adaptability across diverse environmental scenarios.Our flagship software, NODES™, leverages advanced artificial intelligence, data science, andbioinformatics to transform vast amounts of crop data into actionable insights. This enables agricultural companies to optimize their R&D programs, reducing costs, enhancing efficiency, and minimizing environmental impact.At Calice, we believe that the future of agriculture lies in harnessing the power of science and technology to create sustainable and resilient farming practices. Our mission is to contribute to a more sustainable world by helping our clients develop better crops and products, ensuring that natural and productive resources are universally accessible.Join us as we lead the next revolution in agriculture, fostering growth and resilience for a more prosperous and environmentally conscious future.
• metaBIX Biotech — Predictive technology for emerging pathogen and microbiological risk for the agrifood sector from environmental samples.

Portfolio highlights

• Mamotest — Mamotest is a data-driven patient end-to-end solution defeating breast cancer. It goes from awareness and high-quality imaging diagnosis to patient journey follow-up. We collect medical and clinical data and care for psychological and socio-economic data. That broader scope with 100% patient traceability allows us to put vital information in thehands of global business and policy decision-makers, giving them the power to save hundreds of thousands of women's lives.
• Bankingly — Bankingly provides Digital Banking Channels for financial institutions allowing them to improve customer experience, gain new ones and save costs.
• BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.

Portfolio highlights

• Pulpos — Pulpos objective is to provide the greatest product available on the market, complete with an interface that enables retailers to open a store from the cloud in a matter of minutes and with the support they need.
• BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.
• aviva — Aviva is building an AI-powered digital bank for Latin America’s underserved communities. While determined to fuel Latin America’s ongoing emergence of a new middle class with a fully-fledged portfolio of inclusive financial services, Aviva’s initial go-to-market concentrates on unsecured credit products for individuals and nano-businesses inMexico.As most of the underbanked 40+ million Mexicans live in small and medium-sized towns, Aviva builds a bridge to those living in remote communities with its physical onboarding kiosks. These nano-branches provide a documentless 3-minute video onboarding for everyone in need of liquidity. Novel AI-based technology, including natural language processing, allows Aviva to match customers’ spoken word to the fields of a comprehensive real-time credit application. Transforming speech to text and inferring emotions and personality from the visual layer of the application video gives Aviva an edge in scoring thin-file customers. Leveraging these novel risk models, Aviva aims to provide the lowest interest rates available to today’s underserved.

Portfolio highlights

• Prenosis — Prenosis Inc. is a health tech innovator devoted to ushering in a new era of precision diagnostics in acute care using artificial intelligence. Its ImmunixTM precision diagnostics platform leverages machine learning algorithms trained on deep biological data and broad clinical data to more holistically capture and illuminate the complex healthstates of patients. Its proprietary NOSISTM dataset is the largest and fastest growing hybrid biomarker-clinical dataset for sepsis care. The Sepsis ImmunoScoreTM diagnostic on the ImmunixTM platform has the potential to save thousands of lives and billions of dollars in healthcare spending annually.
• Vitestro — Vitestro transform patient care with autonomous blood drawing technology.
• BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.

Portfolio highlights

• NexCure — NexCure expands access to advanced cancer therapies through outpatient clinics, delivering compassionate, innovative care with AI integration for better outcomes.
• Triomics — Triomics | We advance oncology research and care operations by helping accelerate trial enrollment, quality improvement projects, streamline healthcare operations, and more.
• Modicus Prime — Bringing Self-Service AI to the Life Sciences

Portfolio highlights

• BIOMAKERS — BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient treatment.